Related Experiment Videos

Quantitation of microalbuminuria using random urine samples

Farahnak K Assadi1

  • 1Section of Pediatric Nephrology, Rush Medical College, Rush Children's Hospital, Chicago, IL 60612, USA. fassadi@rush.edu

Insights

A random urine microalbumin-creatinine ratio (U(MA)/U(Cr)) accurately monitors microalbuminuria in diabetic patients. This simple method may replace cumbersome 24-hour urine collections for assessing kidney disease risk.

Area of Science:

  • Nephrology
  • Diabetology
  • Clinical Chemistry

Background:

  • Microalbuminuria is a key indicator of diabetic kidney disease and cardiovascular complications.
  • Traditional 24-hour urine collection for microalbuminuria is inconvenient and prone to errors.
  • A simpler, reliable method for monitoring microalbuminuria is needed.

Purpose of the Study:

  • To evaluate the correlation between the microalbumin-creatinine ratio (U(MA)/U(Cr)) in random urine samples and 24-hour microalbumin excretion.
  • To determine if U(MA)/U(Cr) can serve as a practical alternative to timed urine collections for microalbuminuria assessment in pediatric patients with type 1 diabetes.

Main Methods:

  • A study involving 124 urine samples from 97 pediatric patients with type 1 diabetes.
  • Comparison of U(MA)/U(Cr) in a random morning voided urine sample against microalbumin quantity in a 24-hour urine collection.
  • Statistical analysis to determine the correlation coefficient (r) and significance (P-value).

Main Results:

  • An excellent correlation (r=0.89, P<0.001) was observed between random U(MA)/U(Cr) and 24-hour microalbumin excretion.
  • Patients with >30 mg/24h microalbumin excretion consistently showed U(MA)/U(Cr) >20 microg/mg.
  • U(MA)/U(Cr) <20 microg/mg suggested the absence of significant microalbuminuria.

Conclusions:

  • Measurement of U(MA)/U(Cr) in a random second morning voided specimen is a simple and reliable method for monitoring microalbuminuria.
  • This approach may obviate the need for 24-hour urine collections in diabetic patients.
  • The findings support the use of random urine U(MA)/U(Cr) for routine screening and management of diabetic nephropathy.

Related Concept Videos